查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363377

研究级蛋白质市场规模、份额和趋势分析报告：按产品、按宿主细胞、按最终用途、按地区、按细分市场、预测，2023-2030 年

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

研究级蛋白质市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球研究级蛋白质市场规模将达到26.9亿美元，2023年至2030年年复合成长率为15.53%。

癌症研究领域研发投资的增加和个体化药物需求的增加预计将有助于市场成长。此外，许多国家的政府对各种临床研究的投资正在增加，预计这将推动市场成长。此外，新兴国家生物技术产业的不断进步进一步推动了预测期内的市场成长。

由于疫苗、诊断和治疗方法开发的研究活动激增，COVID-19 大流行对市场产生了积极影响。随着法规专注于加快候选疫苗的核准流程，对合约製造的需求增加。儘管 mRNA 疫苗等新型疫苗平台受到了广泛关注，但重组蛋白疫苗的几种替代也在评估中。例如，2022 年 7 月，Novavax 的 COVID-19 疫苗 (NVX-CoV2373) 获得了在欧盟使用的延长有条件行销核准。此外，疫情凸显了生技药品对敏捷、灵活的製造能力的需求。预计这一要素将在不久的将来增强竞争形势并推动市场成长。

据 Global Genes 称，截至 2019 年 10 月，全球有超过 4 亿人患有罕见或遗传性疾病。这个数字表明迫切需要健康意识以及治疗方法和临床环境的改进。对药物标靶机制的先进研究和知识的需求对于药物开发至关重要。在许多地区，队列计划透过开发生物库并为研究人员提供高品质样本，彻底改变了治疗配合措施。因此，预计对各种疾病的生物标记的研究将受到更多关注。因此，研究配合措施和政府对建立更好的医疗基础设施的兴趣预计将增强研究级蛋白质的应用，从而推动市场成长。

然而，蛋白质生产是一个耗时的过程，而这个过程往往需要对工作条件进行高度维护和管理。儘管对这些重组产品的需求很高且不断增长，但法规机构的支持仍然进展缓慢。研究级蛋白质通常透过宿主或表现系统产生，其中透过转染、细菌转化或病毒导入阶段来表达目标产物的特异性基因。这个复杂的过程常常会受到非目标区域过度表现的影响，而且也很耗时。因此，缺乏有关重组技术的具体指南和法规是阻碍研究级蛋白质市场繁荣的主要要素。

研究级蛋白质市场报告亮点

  • 按产品，细胞激素和生长因子领域市场占据市场主导地位，2022 年收益占有率最高，为 23.36%，预计该领域在预测期内将以 17.62% 的最快年复合成长率增长。这是由于它在药物研发和药物开发的各种临床试验中的作用。
  • 从宿主细胞来看，哺乳动物细胞细分市场占主导地位，2022年收益占有率最高，达55.73%。如此大的份额主要是由于其生物结构与人类细胞相似，可用于生产单株抗体和疫苗等生物製药。
  • 依最终用途，製药和生技公司占最大份额，2022年将达61.35%。由于药物研发发现和开发的研究活动增加以及对个体化药物的需求增加，预计在预测期内对研究级蛋白质的需求将增加。
  • 按地区划分，北美占据市场主导地位，2022 年销售额份额为 44.86%。这一巨大份额归因于主要市场参与者和强大的医疗基础设施的存在。预计这些要素将在预测期内推动该地区的研究级蛋白质市场。

目录

第1章研究级蛋白质市场：调查方法与范围

第2章研究级蛋白质市场：执行摘要

  • 市场概述
  • 分段简介
  • 竞争形势概览

第3章研究级蛋白质市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场趋势及展望
  • 市场动态
    • 在研究活动中增加重组蛋白的使用
    • 扩大药物研发和精准医学的研究活动
    • 生技药品和生物相似药的采用增加
  • 市场抑制因素分析
    • 有关蛋白质生产的法规和安全问题
    • 缺乏熟练的人员和专业知识
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第4章按产品业务分析

  • 研究级蛋白质市场：产品变异分析
  • 细胞激素和生长因子
    • 干扰素 (IFN)
    • 白细胞介素 (IL)
    • 其他的
  • 抗体
  • 免疫检查点蛋白
  • 病毒抗原
  • 酵素
    • 激酶
    • 代谢酵素
    • 其他的
  • 重组调节蛋白
  • 荷尔蒙
  • 其他的

第5章宿主细胞的业务分析

  • 研究级蛋白质市场：宿主细胞变异分析
  • 哺乳动物细胞
  • 细菌细胞
  • 酵母和真菌
  • 昆虫细胞
  • 其他的

第6章最终用途的业务分析

  • 研究级蛋白质市场：最终用途变化分析
  • 製药和生物技术公司
  • 学术研究所
  • 其他的

第7章区域业务分析

  • 区域市场简介
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率/地位分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc.
    • Abcam Plc
    • Miltenyi Biotec
    • GenScript
    • Bio-Techne
    • Proteintech Group, Inc.
    • ACROBiosystems
    • Sino Biological, Inc.
    • Prospec-Tany Technogene Ltd.
    • New England Biolabs
Product Code: GVR-4-68040-130-6

Research-grade Proteins Market Growth & Trends:

The global research-grade proteins market size is estimated to reach USD 2.69 billion by 2030, growing at a CAGR of 15.53% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.'s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights:

  • Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.36% in 2022 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
  • Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2022. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
  • Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.35% in 2022. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
  • Based on region, North America dominated the market with a revenue share of 44.86% in 2022. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Host Cell Segment
    • 1.2.3. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Research-grade Proteins Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing use of recombinant proteins in research activities
    • 3.3.2. Growing research activities for drug discovery and precision medicine
    • 3.3.3. Rising adoption of biologics & biosimilars
  • 3.4. Market Restraint Analysis
    • 3.4.1. Regulatory and safety concerns regarding protein production
    • 3.4.2. Dearth of skilled personnel and expertise
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Research-grade Proteins Market: Product Movement Analysis
  • 4.2. Cytokines & Growth Factors
    • 4.2.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.2.2. Interferons (IFNs)
      • 4.2.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
    • 4.2.3. Interleukins (ILs)
      • 4.2.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Antibodies
    • 4.3.1. Antibodies, 2018 - 2030 (USD Million)
  • 4.4. Immune Checkpoint Proteins
    • 4.4.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
  • 4.5. Virus Antigens
    • 4.5.1. Virus Antigens Market, 2018 - 2030 (USD Million)
  • 4.6. Enzymes
    • 4.6.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.6.2. Kinases
      • 4.6.2.1. Kinases Market, 2018 - 2030 (USD Million)
    • 4.6.3. Metabolic Enzymes
      • 4.6.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.7. Recombinant Regulatory Proteins
    • 4.7.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
  • 4.8. Hormones
    • 4.8.1. Hormones Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

  • 5.1. Research-grade Proteins Market: Host Cell Movement Analysis
  • 5.2. Mammalian Cells
    • 5.2.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
  • 5.3. Bacterial Cells
    • 5.3.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 5.4. Yeast & Fungi
    • 5.4.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 5.5. Insect Cells
    • 5.5.1. Insect Cells Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Research-grade Proteins Market: End-use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Scenario
      • 7.2.2.4. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Scenario
      • 7.2.3.4. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Scenario
      • 7.3.5.4. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Scenario
      • 7.3.6.4. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Scenario
      • 7.3.7.4. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Scenario
      • 7.3.8.4. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Scenario
      • 7.3.9.4. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Mexico Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Abcam Plc
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Miltenyi Biotec
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Product Benchmarking
      • 8.4.3.3. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Techne
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Proteintech Group, Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. ACROBiosystems
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. Sino Biological, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. Prospec-Tany Technogene Ltd.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. New England Biolabs
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Product Benchmarking
      • 8.4.10.3. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 6 North America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 9 U.S research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 12 Canada research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 16 Europe research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 19 UK research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 22 Germany research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 24 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 25 France research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 27 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 28 Italy research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 31 Spain research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 33 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 34 Denmark research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 36 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 37 Sweden research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 39 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 40 Norway research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 46 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 47 China research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 49 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 50 Japan research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 52 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 53 India research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 55 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 56 South Korea research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 58 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 59 Australia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 62 Thailand research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 64 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 65 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 66 Latin America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 68 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 69 Brazil research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 71 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 72 Mexico research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 75 Argentina research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 82 South Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 88 UAE research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
  • Table 91 Kuwait research-grade proteins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global research-grade proteins market- Key market driver analysis
  • Fig. 7 Global research-grade proteins market - Key market restraint analysis
  • Fig. 8 Global research-grade proteins market - Porter's analysis
  • Fig. 9 Global research-grade proteins market - PESTEL analysis
  • Fig. 10 Global research-grade proteins market: Product outlook key takeaways
  • Fig. 11 Global research-grade proteins market: Product movement analysis
  • Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
  • Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
  • Fig. 27 Global research-grade proteins market: Host cells movement analysis
  • Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global research-grade proteins market: End-use outlook key takeaways
  • Fig. 34 Global research-grade proteins market: End-use movement analysis
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Global research-grade proteins market: Regional movement analysis
  • Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 44 UK research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 46 France research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 China research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 55 India research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
  • Fig. 68 Strategy framework